HAGSTROM WILLIAM A 4

4 · CareDx, Inc. · Filed May 30, 2025

Form 4

Period: 2025-05-28

Director

Transactions

Exercise/Conversion
Stock Option (right to buy)
2025-05-28−510→ 0 total
Exercise: $5.85Exp: 2025-06-17→ Common Stock (510 underlying)
Exercise/Conversion
Common Stock
2025-05-28$7.96/sh+24,745$196,970→ 83,469 total
Exercise/Conversion
Common Stock
2025-05-28$5.85/sh+510$2,984→ 83,979 total
Sale
Common Stock
2025-05-28$17.45/sh−30,000$523,413→ 53,979 total
Exercise/Conversion
Stock Option (right to buy)
2025-05-28−4,745→ 0 total
Exercise: $4.95Exp: 2026-07-15→ Common Stock (4,745 underlying)
Exercise/Conversion
Common Stock
2025-05-28$4.95/sh+4,745$23,488→ 58,724 total
Exercise/Conversion
Stock Option (right to buy)
2025-05-28−24,745→ 4,391 total
Exercise: $7.96Exp: 2033-06-16→ Common Stock (24,745 underlying)

Footnotes (4)

[F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.35 to $17.57, inclusive. The reporting person undertakes to provide to CareDx, Inc., any security holder of CareDx, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
[F2]The shares subject to this option vested fully on July 1, 2017.
[F3]The shares subject to this option vested fully on June 16, 2024.
[F4]The shares subject to this option vested fully on June 17, 2016.

Documents

1 file